Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: Evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 4039-4048

  Ray, Alpana ^a,b   Bal, B Sonny ^b   Ray, Bimal K ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE B; INTERLEUKIN 1BETA; NUCLEOTIDE; SERUM AMYLOID A ACTIVATING FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; DOG; GENE DELETION; GENE INDUCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; JOINT CAPSULE; MUTANT; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SYNOVIOCYTE; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 24744433752     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.4039     Document Type: Article

References (36)

1. Woessner, J. F., Jr. 2002. MMPs and TIMPs: an historical perspective. Mol. Biotechnol. 22: 33-49.
2. McCawley, L. J., and L. M. Matrisian. 2001. Matrix metalloproteinases: they're not just for matrix anymore. Curr. Opin. Cell Biol. 13: 534-540.
3. Shipley, J. M., G. A. Doyle, C. J. Fliszar, Q. Z. Ye, L. L. Johnson, S. D. Shapiro, H. G. Welgus, and R. M. Senior. 1996. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases: role of the fibronectin type II-like repeats. J. Biol. Chem. 271: 4335-4341.
4. Nguyen, Q., G. Murphy, C. E. Hughes, J. S. Mort, and P. J. Roughley. 1993. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem. J. 295: 595-598.
5. Duffy, M. J., T. M. Maguire, A. Hill, E. McDermott, and N. O'Higgins. 2000. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2: 252-257.
6. Crowe, D. L., and T. N. Brown. 1999. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. Neoplasia 1: 368-372.
7. Martel-Pelletier, J., D. J. Welsch, and J. P. Pelletier. 2001. Metalloproteases and inhibitors in arthritic diseases. Best Practice & Research in Clinical Rheumatology 15: 805-829.
8. Galis, Z. S., and J. J. Khatri. 2002. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90: 251-262.
9. Fini, M. E., W. C. Parks, W. B. Rinehart, M. T. Girard, M. Matsubara, J. R. Cook, J. A. West-Mays, P. M. Sadow, R. E. Burgeson, J. J. Jeffrey, et al. 1996. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am. J. Pathol. 149: 1287-1302.
10. Okada, Y., H. Tsuchiya, H. Shimizu, K. Tomita, I. Nakanishi, H. Sato, M. Seiki, K. Yamashita, and T. Hayakawa. 1990. Induction and Stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor α. Biochem. Biophys. Res. Commun. 171: 610-617.
11. Watanabe, H., I. Nakanishi, K. Yamashita, T. Hayakawa, and Y. Okada. 1993. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell Sci. 104: 991-999.
12. Wahl, S. M., J. B. Allen, B. S. Weeks, H. L. Wong, and P. E. Klotman. 1993. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA 90: 4577-4581.
13. Saarialho-Kere, U. K., H. G. Welgus, and W. C. Parks. 1993. Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem. 268: 17354-17361.
14. Mauviel, A. 1993. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53: 288-295.
15. Sato, H., and M. Seiki. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405.
16. Sato, H., M. Kita, and M. Seiki. 1993. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements: a mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268: 23460-23468.
17. Gum, R., E. Lengyel, J. Juarez, J. H. Chen, H. Sato, M. Seiki, and D. Boyd. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271: 10672-10680.
18. Farina, A. R., A. Tacconelli, A. Vacca, M. Maroder, A. Gulino, and A. R. Mackay. 1999. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor κB elements. Cell Growth Differ. 10: 353-367.
19. Mohan, R., W. B. Rinehart, P. Bargagna-Mohan, and M. E. Fini. 1998. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling. J. Biol. Chem. 273: 25903-25914.
20. Kaneko, M., T. Tomita, T. Nakase, Y. Ohsawa, H. Seki, E. Takeuchi, H. Takano, K. Shi, K. Takahi, E. Kominami, et al. 2001. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology 40: 247-255.
21. Ahrens, D., A. E. Koch, R. M. Pope, M. Stein-Picarella, and M. J. Niedbala. 1996. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 39: 1576-1587.
22. Okada, Y., K. Naka, K. Kawamura, T. Matsumoto, I. Nakanishi, N. Fujimoto, H. Sato, and M. Seiki. 1995. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72: 311-322.
23. Masuhara, K., T. Nakai, K. Yamaguchi, S. Yamasaki, and Y. Sasaguri. 2002. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Arthritis Rheum. 46: 2625-2631.
24. Masuhara, K., S. Bak Lee, T. Nakai, N. Sugano, T. Ochi, and Y. Sasaguri. 2000. Matrix metalloproteinases in patients with osteoarthritis of the hip. Int. Orthop. 24: 92-96.
25. Sanceau, J., D. D. Boyd, M. Seiki, and B. Bauvois. 2002. Interferons inhibit tumor necrosis factor-α-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-κB. J. Biol. Chem. 277: 35766-35775.
26. Henderson, B., and E. R. Pettipher. 1989. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor a in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin. Exp. Immunol. 75: 306-310.
27. Ray, A., and B. K. Ray. 1998. Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter. Mol. Cell. Biol. 18: 7327-7335.
28. Outerbridge, R. E. 1961. The etiology of chondromalacia patellae. J. Bone Jt. Surg. Br. 43: 752-757.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Plainview, NY.
30. Kim, S. J., H. D. Lee, P. D. Robbins, K. Busam, M. B. Sporn, and A. B. Roberts. 1991. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc. Natl. Acad. Sci. USA 88: 3052-3056.
31. Dynan, W. S., and R. Tjian. 1983. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35: 79-87.
32. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240-246.
33. Ray, A., H. Schatten, and B. K. Ray. 1999. Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J. Biol. Chem. 274: 4300-4308.
34. Perkins, N. D. 1997. Achieving transcriptional specificity with NF-κB. Int. J. Biochem. Cell Biol. 29: 1433-1448.
35. Liberati, N. T., M. B. Datto, J. P. Frederick, X. Shen, C. Wong, E. M. Rougier-Chapman, and X. F. Wang. 1999. Smads bind directly to the Jun family of AP-1 transcription factors. Proc. Natl. Acad. Sci. USA 96: 4844-4849.
36. Ramirez-Carrozzi, V.R., and T. K. Kerppola. 2001. Control of the orientation of Fos-Jun binding and the transcriptional cooperativity of Fos-Jun-NFAT1 complexes. J. Biol. Chem. 276: 21797-21808.